General Information
Drug ID
DR00805
Drug Name
GSK239512
Synonyms
1-(6-((3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YL)OXY)PYRIDIN-3-YL)PYRROLIDIN-2-ONE; 2-Pyrrolidinone, 1-(6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-3-pyridinyl)-; 4I7U5C459M; 720691-69-0; AK171368; AKOS025291102; AS-42474; BDBM50444496; CHEMBL3092650; GSK-239512; GSK239512; J3.497.402K; KS-0000063Q; MolPort-035-776-189; SB16754; SCHEMBL167578; UNII-4I7U5C459M; YFRBKEVUUCQYOW-UHFFFAOYSA-N; ZINC3961802
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Formula
C23H27N3O2
Canonical SMILES
C1CC(C1)N2CCC3=C(CC2)C=C(C=C3)OC4=NC=C(C=C4)N5CCCC5=O
InChI
InChI=1S/C23H27N3O2/c27-23-5-2-12-26(23)20-7-9-22(24-16-20)28-21-8-6-17-10-13-25(19-3-1-4-19)14-11-18(17)15-21/h6-9,15-16,19H,1-5,10-14H2
InChIKey
YFRBKEVUUCQYOW-UHFFFAOYSA-N
Pharmaceutical Properties Molecular Weight 377.5 Topological Polar Surface Area 45.7
Heavy Atom Count 28 Rotatable Bond Count 4
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 4
XLogP
3.4
PubChem CID
9976892
TTD Drug ID
D07YGH

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.